Latest News

Digital therapeutics startup Akili Interactive inks deal with Japanese pharma company


In exchange for ceding rights to develop, sell and market Akili’s two lead products in Japan and Taiwan to Shionogi, Akili will receive $20 million upfront and up to $105 million in additional payments dependent on reaching certain development and commercial milestones.

Source link

Related posts

High pressure behaviour of pyroxenes

Newsemia

SPG Media’s 25-Year-Old CEO Finds Success Telling the Story of Your Health’s Future

Newsemia

HEMAsavR Helps to Recover More Intraop Blood

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World